Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors. - Wikidata - wikimedia - TriplyDB

Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors.

Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors.

http://www.wikidata.org/entity/Q37429524

about

Biological markers of invasive breast cancer Circulating DNA as biomarker in breast cancer Free DNA--new potential analyte in clinical laboratory diagnostics?The Roles of Mitochondrial Damage-Associated Molecular Patterns in Diseases Origins, structures, and functions of circulating DNA in oncology Methyl-binding domain protein-based DNA isolation from human blood serum combines DNA analyses and serum-autoantibody testing.Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations.Plasma Mitochondrial DNA Levels as a Biomarker of Lipodystrophy Among HIV-infected Patients Treated with Highly Active Antiretroviral Therapy (HAART).Circulating DNA in rheumatoid arthritis: pathological changes and association with clinically used serological markers.Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis Repeated bouts of exhaustive exercise increase circulating cell free nuclear and mitochondrial DNA without development of tolerance in healthy men Circulating Tumor Nucleic Acids: Perspective in Breast Cancer.Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation The plasma mitochondrial DNA is an independent predictor for post-traumatic systemic inflammatory response syndrome.An exposure to the oxidized DNA enhances both instability of genome and survival in cancer cells.Mitochondrial dysfunction in cancer cells due to aberrant mitochondrial replication.Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer.Plasma nuclear and mitochondrial DNA levels in acute myocardial infarction patients.Silencing of uncoupling protein 2 by small interfering RNA aggravates mitochondrial dysfunction in cardiomyocytes under septic conditions.Very Short Mitochondrial DNA Fragments and Heteroplasmy in Human Plasma.Quantitative analysis of cell-free DNA in ovarian cancer.Aberrant reduction of telomere repetitive sequences in plasma cell-free DNA for early breast cancer detection.Plasma cell-free mitochondrial DNA declines in response to prolonged moderate aerobic exercise.Prevalent coordination of mitochondrial DNA transcription and initiation of replication with the cell cycle Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection.Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology.Altered Striatocerebellar Metabolism and Systemic Inflammation in Parkinson's Disease Potential biomarkers to follow the progression and treatment response of Huntington's disease.Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients.Circulating nucleic acids as biomarkers in breast cancer.Cell-free and cell-bound circulating nucleic acid complexes: mechanisms of generation, concentration and content.Circulating cell-free mitochondrial DNA as a novel cancer biomarker: opportunities and challenges.Predictive biomarkers in breast cancer: their value in neoadjuvant chemotherapy.Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients.A headlight on liquid biopsies: a challenging tool for breast cancer management.The pharmacoepigenetics of drug metabolism and transport in breast cancer: review of the literature and in silico analysis.Beneficial effects of exercise on age-related mitochondrial dysfunction and oxidative stress in skeletal muscle.Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases.Fueling Inflamm-Aging through Mitochondrial Dysfunction: Mechanisms and Molecular Targets.Reduced cerebrospinal fluid mitochondrial DNA is a biomarker for early-stage Parkinson's disease.

P2860

Q26781177-2E381D48-DF70-48A9-991A-1C93724614F7 Q26785343-BE7F2ECF-6EE8-4D0F-9DE8-4E870C50C458 Q26863327-3408B57F-A8EE-4C2C-943B-C1B477F1CFA4 Q28396823-C2A9EB2A-E474-4AEF-9BDB-54F51D3DB455 Q30249103-30C44622-7102-4C7E-AD63-78BDA748AB7A Q31030113-9AECEE8E-4715-4AF5-B49B-8319D0E6896A Q33577711-47ACAE85-E7A0-4F7B-B974-19F99D4F0797 Q33600363-90F2488F-E926-4117-88B2-048FE4B5E664 Q33629819-53FCA39C-23B7-47E7-BCB4-C38453BCD1F9 Q33688767-9E7F3FE4-4E3B-43E5-9C63-21392FB94645 Q33725026-4D7500F1-05F8-40F0-8F96-549E2CCD56C9 Q34096001-9AA3FF12-1E93-4AEF-8133-38422EEAE7CD Q34660102-CA9DCB7B-CA54-4668-9BB6-AFFFCD8E5A2B Q34974108-F539DBDC-5EB4-410A-964E-8081BC5CB496 Q35023150-9CCBC8AB-C5C6-4619-8BEE-24D59D24B367 Q35063098-CC2607B7-8125-4BB9-8895-904FB1798BF2 Q35148262-BD0F746F-E6E5-4C7B-96D2-06C4BB4E5A1B Q35558298-9A71D925-901C-4E66-B4EB-9BE40A5EB83C Q35609951-957FF1AC-DC68-46E2-9F46-0B0E9E1F6EE3 Q36181880-357CCCB9-1ED0-408A-AD1C-552C8AA14362 Q36334715-2C52D240-6AA0-4B82-AD0A-ABE20D7C2638 Q36557431-85A0553D-985B-4EF8-837D-F21FD63A57CF Q36597722-E5855D8D-2649-439B-9195-F5F9FA9C770E Q36684815-28507E5F-16AF-4EC8-891A-FB9DA3530CC2 Q36785190-CAC08F8D-60AB-499E-89CC-0BF169CCDA37 Q37014663-229DE5C6-879E-4F2B-AC72-D6B48CD9FF7B Q37256739-35506196-491B-46FE-8260-CE6EC37D2A51 Q37415254-069F1D01-0129-4243-85DE-EC725ADFC6BD Q37522662-735F5D7E-62C0-43A8-B6AD-CEF883D4C55D Q37690204-840F8A13-9B5D-4A46-B8B3-1CB9B97939BA Q38002456-2C59C518-4B9E-4390-9C5E-E8B2CAA41171 Q38024847-127000C2-0E6C-47CC-95EB-CBDD84C24E26 Q38047337-BAF76C4A-EC7A-4BF3-975C-736F192D24F8 Q38669236-684F6E17-3A5C-4C61-BB2F-CEBA6673D744 Q38704258-0271E9B9-C1C9-4030-BDF3-957896F465A4 Q38937221-8948E6E4-0DA1-4069-A17C-83700FDB09C9 Q38949760-3B7EE0F2-D50B-4CBE-A56E-8FE8F8583325 Q39181159-E1034CB2-B093-4584-B99B-A34E80CCDD80 Q39269625-A555687B-E453-48F0-ABC2-923B96B4C4B1 Q40568866-784A208C-F829-43F5-9201-A316B014ABC3

P2860

Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors.

http://www.wikidata.org/entity/Q37429524

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Levels of plasma circulating c ...... biomarkers for breast tumors.

@en

Levels of plasma circulating c ...... biomarkers for breast tumors.

@nl

type

label

Levels of plasma circulating c ...... biomarkers for breast tumors.

@en

Levels of plasma circulating c ...... biomarkers for breast tumors.

@nl

prefLabel

Levels of plasma circulating c ...... biomarkers for breast tumors.

@en

Levels of plasma circulating c ...... biomarkers for breast tumors.

@nl

P1433

Q37429524-9E9C3787-7A9B-49A1-AB47-59C21CB69771

P1476

Q37429524-0A15E1D6-686C-4340-B817-421A2313D0D7

P2093

Q37429524-1D1A6AC8-942E-4CF3-890F-9E9D3160354A

Q37429524-60934710-7F64-42C9-9B2E-9AFB20D9CD95

Q37429524-68886579-2331-41C9-9E36-45D6181BA80B

Q37429524-7374DDE1-8D43-4DB6-A66B-E5EC0579FEC7

Q37429524-75AE14C8-FA91-4C5A-97E7-7B7FD212A1EA

Q37429524-961BAD40-757F-45A7-BAF5-C309B1F82041

Q37429524-D52B8018-2661-449C-A4A9-6AD53AFD26C4

Q37429524-E2021015-1D17-4C62-BB0A-49D0693C6B0D

Q37429524-F097F8C7-2EF4-4B32-8465-0E8B3C5955E1

P2860

Q37429524-003E4019-8432-4E6D-82E6-F4C02CFDD803

Q37429524-188B55A1-3E0C-4282-9500-F5D1A54B664F

Q37429524-207CEE05-9A12-4B91-AD48-991CC9DC30DF

Q37429524-2D184C26-9458-4175-B264-FF849221F325

Q37429524-5AB1493A-8D1C-4706-AC34-5697D704160F

Q37429524-5DD255DB-0E4A-4753-B0A0-5A2612BD39B1

Q37429524-60739269-7CB7-4FCD-972A-AF93BF072E7B

Q37429524-6676DD55-073C-4A23-BDE8-2FB4C0E31D75

Q37429524-6C92588E-E7FB-47C2-8D9A-922CA0340A61

Q37429524-79F190B6-7E24-4184-8E47-87CC3CF87316

P2888

Q37429524-7EA420C1-2859-4512-B90E-51F26609443D

P304

Q37429524-3B44E2B8-5791-4868-845A-6051E9E05C3A

P31

Q37429524-F9770D5F-B151-4D2A-B491-2A8B91DC4BE1

P356

Q37429524-859487A5-5FC4-42A2-A771-DEA3E3CCB714

P478

Q37429524-B9CB3754-9740-4464-9962-5D9021CE004E

P50

Q37429524-6FFC2442-6251-46A7-B8F5-85E73CCB5731

P577

Q37429524-A56F0812-63FB-4127-B7EB-499090694340

P5875

Q37429524-A1700B4F-C204-4A7D-A783-A17022A86D43

P6179

Q37429524-91106774-31C0-4B84-96AE-435248F2AD86

P698

Q37429524-F02C70E6-209B-42A0-A8E5-AA4EBFFA20E7

P921

Q37429524-90D037ED-9FDF-4F0B-91FD-B12C8B6CD34D

Q37429524-E804A652-DCD7-4E94-81AC-6A5F11408865

P932

Q37429524-414AE656-E227-4D6C-8C58-6FAB64008CED

P356

1476-4598-8-105

P1433

Molecular Cancer

P1476

Levels of plasma circulating c ...... l biomarkers for breast tumors

@en

P2093

Claude Diesch

http://www.w3.org/2001/XMLSchema#string

Corina Kohler

http://www.w3.org/2001/XMLSchema#string

Edward Wight

http://www.w3.org/2001/XMLSchema#string

Johannes Bitzer

http://www.w3.org/2001/XMLSchema#string

Nicole Bürki

http://www.w3.org/2001/XMLSchema#string

Reza Asadollahi

http://www.w3.org/2001/XMLSchema#string

Wolfgang Holzgreve

http://www.w3.org/2001/XMLSchema#string

Xiao Yan Zhong

http://www.w3.org/2001/XMLSchema#string

Zeinab Barekati

http://www.w3.org/2001/XMLSchema#string

P2860

Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer

Circulating mutant DNA to assess tumor dynamics

Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer

Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases

Increased distributional variance of mitochondrial DNA content associated with prostate cancer cells as compared with normal prostate cells

Fetal DNA in maternal plasma: biology and diagnostic applications.

Simultaneous quantitative assessment of circulating cell-free mitochondrial and nuclear DNA by multiplex real-time PCR.

Multiple biomarkers for the prediction of first major cardiovascular events and death.

Tumor markers in breast cancer- European Group on Tumor Markers recommendations.

Cancer biomarkers: a systems approach.

P2888

1476-4598-8-105

P304

105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-4598-8-105

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38098361

http://www.w3.org/2001/XMLSchema#string

P6179

1025246487

http://www.w3.org/2001/XMLSchema#string

P698

19922604

http://www.w3.org/2001/XMLSchema#string

P921

mitochondrial DNA

P932

2780981

http://www.w3.org/2001/XMLSchema#string